Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Celebrex Long-Term Safety Monitoring Results Reassure FDA

Nov 08 2004

• By The Pink Sheet

Related Content

Pfizer Goes On Offense With Celebrex: TV Ads, Study Proposal Stress Safety

Oct 25 2004

Merck After Vioxx: No Merger, But No Big Near-Term Launches

Oct 04 2004

COX-2 Retrospective Study Prompts Review By FDA, Kaiser On Merck’s Vioxx

Aug 30 2004

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window